Trial intelligence / Profile preview

Methylphenidate modulation of memory and exam performance

NL-OMON52652Completed

Sponsor
Maastricht University
Start
Nov 2020
Modality
Small Molecules
Countries
1
01

Overview

Trial of methylphenidate (2 arms), sponsored by Maastricht University. Primary endpoints: Exam performance: factual knowledge and Exam performance: understanding/insight. Started Nov 2020; status: completed.

02

Drugs

methylphenidate

Beyond the preview

Go deeper on NL-OMON52652.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON52652.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call